MDVN and JNJ Related Headlines

Go Back

Feb 28, 2014 11:30AM Now-Profitable Medivation (MDVN) has XTANDI Approval to Look Forward to; Aegis Keeps at 'Buy'
Jan 29, 2014 09:46AM Aegis Capital Boosts PT on Medivation (MDVN) 25% Following Strong Enzalutamide Data
Oct 22, 2013 10:18AM Aegis Keeps Buy on Medivation (MDVN) Following PREVAIL Analysis; Company Ripe for Takeover (JNJ)

MDVN and JNJ Related Press Releases

Go Back

MDVN and JNJ Related SEC Filings

Go Back